Multi-tissue interactions in an integrated three-tissue organ-on-a-chip platform

Area of Science:

• Biomedical Engineering
• Pharmacology
• Toxicology

Background:

• Many drugs fail due to unforeseen human toxicity after FDA approval.
• Existing in vitro models often lack the integrated physiological complexity of human organs.
• The dynamic, interactive environment of human tissues is crucial for drug response but poorly replicated in current models.

Purpose of the Study:

• To develop advanced bioengineered tissue constructs that mimic inter-organ communication.
• To create an integrated organ-on-a-chip system for studying drug effects in a more physiologically relevant context.
• To demonstrate the utility of multi-tissue integration for predicting drug efficacy and toxicity.

Main Methods:

• Development of bioengineered tissue organoids and constructs.
• Integration of liver, heart, and lung tissues into a closed circulatory perfusion system.
• Administration of drug compounds and observation of inter-organ responses within the system.

Main Results:

• Successfully created a three-tissue organ-on-a-chip system (liver, heart, lung).
• Observed drug responses that were contingent upon interactions between the integrated tissues.
• Demonstrated that inter-tissue communication influences drug efficacy and toxicity profiles.

Conclusions:

• Integrated organ-on-a-chip systems offer a more accurate preclinical drug evaluation platform.
• This multi-tissue approach is valuable for identifying potential drug side effects and efficacy.
• The developed system advances the predictive power of in vitro drug testing by incorporating inter-organ dynamics.